BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3302388)

  • 21. RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins.
    Jeter ML; Ly LV; Fortenberry YM; Whinna HC; White RR; Rusconi CP; Sullenger BA; Church FC
    FEBS Lett; 2004 Jun; 568(1-3):10-4. PubMed ID: 15196911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
    Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma heparin cofactor II, protein C and antithrombin in elective surgery.
    Andersson TR; Berner NS; Larsen ML; Odegaard OR; Abildgaard U
    Acta Chir Scand; 1987 Apr; 153(4):291-6. PubMed ID: 3630527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the determination of heparin cofactor II (HC II) activity using a synthetic chromogenic substrate].
    Ohtsubo M; Asai M; Asai K; Takagi A
    Rinsho Byori; 1987 May; 35(5):565-70. PubMed ID: 3613167
    [No Abstract]   [Full Text] [Related]  

  • 25. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
    Undar L; Ertuğrul C; Altunbaş H; Akça S
    Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin cofactor II: purification and antibody production.
    Tran TH; Lämmle B; Zbinden B; Duckert F
    Thromb Haemost; 1986 Feb; 55(1):19-23. PubMed ID: 3518132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibitors of the serine-proteases of coagulation with special reference to antithrombin III and heparin cofactor II].
    Fontcuberta J
    Sangre (Barc); 1985; 30(4-C):787-91. PubMed ID: 3841417
    [No Abstract]   [Full Text] [Related]  

  • 28. Antithrombin III (ATIII) and heparin cofactor II (HCII) in normal human fetuses (21st-27th week).
    Toulon P; Rainaut M; Aiach M; Roncato M; Daffos F; Forestier F
    Thromb Haemost; 1986 Oct; 56(2):237. PubMed ID: 3810560
    [No Abstract]   [Full Text] [Related]  

  • 29. Heparin cofactor II: a new marker for pre-eclampsia.
    Bellart J; Gilabert R; Cabero L; Fontcuberta J; Monasterio J; Miralles RM
    Blood Coagul Fibrinolysis; 1998 Mar; 9(2):205-8. PubMed ID: 9622221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin Cofactor II: A Novel Plausible Link of Obesity and Diabetes with Thrombosis.
    Hasegawa Y; Ishigaki Y
    J Atheroscler Thromb; 2017 Dec; 24(12):1202-1203. PubMed ID: 28794345
    [No Abstract]   [Full Text] [Related]  

  • 31. Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues.
    Osborne SA; Daniel RA; Desilva K; Seymour RB
    Glycobiology; 2008 Mar; 18(3):225-34. PubMed ID: 18156656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regulation of blood coagulation by heparin and related proteins].
    Takahashi K; Niwa M; Yamagishi R; Sakuragawa N
    Rinsho Ketsueki; 1987 Jul; 28(7):1094-101. PubMed ID: 3694818
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: Coagulation inhibitors studied with chromogenic substrate.
    Abildgaard U; Lie M; Teien A; Odegård OR
    Thromb Diath Haemorrh; 1975 Sep; 34(1):345. PubMed ID: 1188787
    [No Abstract]   [Full Text] [Related]  

  • 34. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heparin cofactor II and thrombophilic conditions].
    Hudecek J; Hal'áková E; Ivanková J; Kubisz P
    Vnitr Lek; 1997 May; 43(5):317-9. PubMed ID: 9601856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of heparin cofactor II].
    Takahashi K; Yamagishi R; Niwa M; Sakuragawa N
    Rinsho Byori; 1987 Apr; Spec No 70():181-6. PubMed ID: 3302388
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antithrombin III and heparin cofactor II].
    Kondo S; Niwa M
    Rinsho Byori; 1985 Feb; Spec No 61():106-13. PubMed ID: 3839027
    [No Abstract]   [Full Text] [Related]  

  • 38. Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapy.
    Toulon P; Vitoux JF; Capron L; Roncato M; Fiessinger JN; Aiach M
    Thromb Res; 1988 Mar; 49(5):497-500. PubMed ID: 3376055
    [No Abstract]   [Full Text] [Related]  

  • 39. Laboratory determination of heparin cofactor II.
    Ezenagu LC; Brandt JT
    Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma heparin cofactor II and antithrombin III concentrations in adult nephrotic syndrome.
    Hannedouche T; Fischer AM; Blanche P; Tapon-Brétaudière J; Ganeval D
    Clin Nephrol; 1987 Dec; 28(6):305-6. PubMed ID: 3442960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.